Surlorian placebo, Surlorian clinical trials

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Efficacy and Safety of surlorian (ARM210, S48168) in Adults with Autosomal Dominant RYR1-Related Myopathy

This study is testing a new medicine, Surlorian, for adults with a muscle condition called Autosomal Dominant RYR1-Related Myopathy. It aims to see if the medicine can improve muscle strength and daily activities, and if it's safe to use.